CONSERVATORY BLINDS DESIGN & MANUFACTURING LTD

Profile CONSERVATORY BLINDS DESIGN & MANUFACTURING LTD

Actual on 01.07.2021
Company name
CONSERVATORY BLINDS DESIGN & MANUFACTURING LTD
copy
copied
Company number
04427189
copy
copied
Company status
Active
copy
copied
Company type
Private Limited Company
copy
copied
Incorporated on
Monday, 29 April 2002
copy
copied
Accounts

Actual

Next accounts made up to 31.03.2021 due by 31.12.2021

Last accounts made up to 31.03.2020

Confirmation statement

Actual

Next statement date Friday, 29 April 2022 due by Friday, 13 May 2022

Last statement dated Thursday, 29 April 2021

Nature of business (SIC)
32990 - Other manufacturing n.e.c.
copy
copied
Registered office address
UNIT 8 GREENLEA PARK, PRINCE GEORGES ROAD, LONDON, MERTON, SW19 2JD
copy
copied

PSC and Officers CONSERVATORY BLINDS DESIGN & MANUFACTURING LTD

Officers

(as of 19.09.2020)

KEEGAN, James Kevin
Status: Active
Appointed on: Friday, 03 May 2002
Correspondence address: 79 Roundwood Way, Banstead, Surrey, SM7 1EJ
Nationality: British
Date of birth: November 1959
Role: Director
Occupation: Blind Manufacturer
Country of residence: England
KEEGAN, John
Status: Active
Appointed on: Friday, 03 May 2002
Correspondence address: 58 Chadacre Road, Stoneleigh, Surrey, KT17 2HE
Role: Secretary
FORM 10 DIRECTORS FD LTD
Status: Not active
Appointed on: Monday, 29 April 2002
Resigned on: Thursday, 02 May 2002
Correspondence address: 39a Leicester Road, Salford, Manchester, M7 4AS
Role: Corporate Nominee Director
FORM 10 SECRETARIES FD LTD
Status: Not active
Appointed on: Monday, 29 April 2002
Resigned on: Thursday, 02 May 2002
Correspondence address: 39a Leicester Road, Salford, M7 4AS
Role: Nominee Secretary
Show all records Hide
Person with significant control

(as of 01.07.2021)

Mr James Kevin Keegan
Status: Active
Notified on: Saturday, 01 April 2017
Correspondence address: Merton, London
Nationality: British
Date of birth: November 1959
Legal form: Individual Person With Significant Control
Country of residence: England
Nature of control:

Ownership Of Shares 25 To 50 Percent